By InvitationNot Applicable

Necrotizing Soft Tissue Infections

Spain480 participantsStarted 2026-01-01

Plain-language summary

SnapNSTI is an international, multicenter, time-bound prospective observational cohort study designed to characterize current epidemiology, management patterns, and outcomes of patients with necrotizing soft-tissue infections (NSTI). The primary objective is to estimate 90-day all-cause mortality and to evaluate the variability in management across centers. The study will also explore the association between clinical characteristics, treatments, and patient-reported outcomes.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥18 years * Diagnosis of necrotizing soft-tissue infection (NSTI) confirmed by: * Surgical or histopathological evidence of fascial necrosis * OR imaging showing gas in the fascial plane * Admitted to a participating hospital during the enrollment period Exclusion Criteria: * Non Severe soft-tissue infection * Patients \<18 years old

What they're measuring

90-day all-cause mortality

Timeframe: 90 days from admission

Trial details

NCT IDNCT07107555

SponsorEuropean Society for Trauma and Emergency Surgery

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-03-31

View on ClinicalTrials.gov More Necrotizing Soft Tissue Infection trials